Virtual screening of bioactive anti-SARS-CoV natural products and identification of 3β,12-diacetoxyabieta-6,8,11,13-tetraene as a potential inhibitor of SARS-CoV-2 virus and its infection related pathways by MD simulation and network pharmacology
Since the first prevalence of COVID-19 in 2019, it still remains the most devastating pandemic throughout the world. The current research aimed to find potential natural products to inhibit the novel coronavirus and associated infection by MD simulation and network pharmacology approach. Molecular d...
Similar Items
Concerns regarding SARS-CoV-2 JN.1 mutations should be raised
by: Roney, Miah, et al.
Published: (2024)
by: Roney, Miah, et al.
Published: (2024)
The SARS-CoV-2 variants and their impacts
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2022)
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2022)
Evolution of SARS-CoV-2 from BA.2.86 to JN.1 variations and detection in Bangladesh
by: Roney, Miah, et al.
Published: (2024)
by: Roney, Miah, et al.
Published: (2024)
Genomic epidemiology of SARS-CoV-2 in Malaysia
by: Chew, Sian Hui
Published: (2025)
by: Chew, Sian Hui
Published: (2025)
Pathophysiology, histopathology and therapeutic of SARS-CoV-2
by: Noman, Efaq, et al.
Published: (2020)
by: Noman, Efaq, et al.
Published: (2020)
Lateral flow immunoassays for SARS-CoV-2
by: Ang, Geik Yong, et al.
Published: (2022)
by: Ang, Geik Yong, et al.
Published: (2022)
In silico selection of aptamers against SARS-CoV-2
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2024)
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2024)
The cell mediated and humoral response to SARS-CoV-2 infection
by: Burns, Eleanor
Published: (2022)
by: Burns, Eleanor
Published: (2022)
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials
by: Lim, Hui Xuan *, et al.
Published: (2021)
by: Lim, Hui Xuan *, et al.
Published: (2021)
Thermophoretic collection of virus-laden (SARS-CoV-2) aerosols
by: Zhang, Xiangzhi, et al.
Published: (2021)
by: Zhang, Xiangzhi, et al.
Published: (2021)
SARS-CoV-2 screening must go beyond sick
by: Abdullah, Syahril
Published: (2020)
by: Abdullah, Syahril
Published: (2020)
Identification of pyrazole derivatives of usnic acid as novel inhibitor of SARS-CoV-2 main protease through virtual screening approaches
by: Roney, Miah, et al.
Published: (2023)
by: Roney, Miah, et al.
Published: (2023)
Identification of pyrazole derivatives of Usnic Acid as Novel Inhibitor of SARS‑CoV‑2 main protease through virtual screening approaches
by: Roney, Miah, et al.
Published: (2023)
by: Roney, Miah, et al.
Published: (2023)
Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy
by: Lee, Vanessa W., et al.
Published: (2024)
by: Lee, Vanessa W., et al.
Published: (2024)
SARS-CoV-2: from origin to treatment and control management strategies
by: Hezam, Kamal, et al.
Published: (2020)
by: Hezam, Kamal, et al.
Published: (2020)
Risk Perceptions of SARS-CoV-2 in the UK: A City-wise Analysis
by: Raza, Naba
Published: (2022)
by: Raza, Naba
Published: (2022)
Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz, Al-Fattah Yahaya *, et al.
Published: (2023)
by: Abdul Aziz, Al-Fattah Yahaya *, et al.
Published: (2023)
Development of multi-epitope peptide-based vaccines against SARS-CoV-2
by: Lim, Hui Xuan *, et al.
Published: (2020)
by: Lim, Hui Xuan *, et al.
Published: (2020)
NK cells: A double edge sword against SARS-CoV-2
by: Masselli, E., et al.
Published: (2020)
by: Masselli, E., et al.
Published: (2020)
SARS-CoV-2 infection and human semen: possible modes of contamination and transmission
by: Bhattacharya, Koushik, et al.
Published: (2021)
by: Bhattacharya, Koushik, et al.
Published: (2021)
Apa yang berlaku pada tubuh apabila berlaku jangkitan SARS-CoV-2 ?
by: Mohd Nasir, Mohd Hamzah
Published: (2020)
by: Mohd Nasir, Mohd Hamzah
Published: (2020)
Isolation and characterisation of bovine ultralong antibodies to SARS-CoV-2 using phage display
by: Park, Emily
Published: (2024)
by: Park, Emily
Published: (2024)
A Fog Computing-based System to Identify SARS - CoV -2 Using Deep Learning
by: Welhenge, Anuradhi
Published: (2021)
by: Welhenge, Anuradhi
Published: (2021)
Identification of SARS-CoV-2 inhibitors from alkaloids using molecular modeling and in silico approaches
by: Roni, Md Abul Hasan, et al.
Published: (2023)
by: Roni, Md Abul Hasan, et al.
Published: (2023)
Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: from alpha to Omicron
by: Choo, Yee Yu, et al.
Published: (2022)
by: Choo, Yee Yu, et al.
Published: (2022)
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection
by: Romani, Arianna, et al.
Published: (2023)
by: Romani, Arianna, et al.
Published: (2023)
Maternal immune activation as a risk factor for psychiatric illness in the context of the SARS-CoV-2 pandemic
by: Lins, Brittney
Published: (2021)
by: Lins, Brittney
Published: (2021)
Construction of multi-epitopes vaccine candidate against SARS-CoV-2 D614G variant
by: Siti Asmaa Mat Jusoh,, et al.
Published: (2022)
by: Siti Asmaa Mat Jusoh,, et al.
Published: (2022)
Increasing Sporadic Covid-19 Cases:Should We Heed Airborne Transmission Of SARS-CoV-2?
by: Ahmad Mahfuz, Gazali
Published: (2021)
by: Ahmad Mahfuz, Gazali
Published: (2021)
Increasing sporadic Covid-19 cases:should we heed airborne transmission of SARS-CoV-2?
by: Ahmad Mahfuz, Gazali
Published: (2021)
by: Ahmad Mahfuz, Gazali
Published: (2021)
Humoral response to SARS-CoV-2 vaccines among healthcare workers in a tertiary hospital in Malaysia
by: Mohd Amin, Amrina, et al.
Published: (2022)
by: Mohd Amin, Amrina, et al.
Published: (2022)
Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
by: Chan, Lee-Chin, et al.
Published: (2023)
by: Chan, Lee-Chin, et al.
Published: (2023)
Identify human cluster of differentiation 147 (CD147), a new target of SARS-CoV-2 invasion
by: Al-Salih, Moatasem, et al.
Published: (2020)
by: Al-Salih, Moatasem, et al.
Published: (2020)
The association of ABO and rhesus blood type with the risks of developing SARS-CoV-2 infection: a meta-analysis
by: Soo, K. M., et al.
Published: (2022)
by: Soo, K. M., et al.
Published: (2022)
A modelling approach to estimate the transmissibility of SARS-CoV 2 during periods of high, low, and zero case incidence
by: Golding, Nick, et al.
Published: (2023)
by: Golding, Nick, et al.
Published: (2023)
Near-complete genome sequences of Nine SARS-CoV-2 strains harboring the D614G mutation in Malaysia
by: Ummu Afeera, Zainulabid, et al.
Published: (2021)
by: Ummu Afeera, Zainulabid, et al.
Published: (2021)
Halal beauty supply chain and sustainable operational excellence: A moderator of the post-SARS-CoV-2 mitigation strategy
by: Fernando, Yudi, et al.
Published: (2024)
by: Fernando, Yudi, et al.
Published: (2024)
Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B.1.524 and AU.2 in Malaysia
by: Ummu Afeera, Zainulabid, et al.
Published: (2022)
by: Ummu Afeera, Zainulabid, et al.
Published: (2022)
Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B.1.524 and AU.2 in Malaysia
by: Zainulabid, Ummu Afeera, et al.
Published: (2022)
by: Zainulabid, Ummu Afeera, et al.
Published: (2022)
Computational drug screening against the SARS-CoV-2 Saudi Arabia isolates through a multiple-sequence alignment approach
by: Mok, Pooi Ling, et al.
Published: (2021)
by: Mok, Pooi Ling, et al.
Published: (2021)
Similar Items
-
Concerns regarding SARS-CoV-2 JN.1 mutations should be raised
by: Roney, Miah, et al.
Published: (2024) -
The SARS-CoV-2 variants and their impacts
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2022) -
Evolution of SARS-CoV-2 from BA.2.86 to JN.1 variations and detection in Bangladesh
by: Roney, Miah, et al.
Published: (2024) -
Genomic epidemiology of SARS-CoV-2 in Malaysia
by: Chew, Sian Hui
Published: (2025) -
Pathophysiology, histopathology and therapeutic of SARS-CoV-2
by: Noman, Efaq, et al.
Published: (2020)